bioRxivAnimal Behavior & Cognition
Disrupted structure and aberrant function of CHIP mediates the loss of motor and cognitive function in preclinical models of cerebellar CHIPopathy
C.-h. Shi, C. Rubel, S. E. Soss, R. Sanchez-Hodge, S. Zhang, D. A. Stevens, H. McDonough, R. C. Page, W. Chazin, C. Patterson, C.-y. Mao, M. S. Willis, H.-Y. Luo, M.-b. Tang, P. Du, Y.-h. Wang, Z.-w. Hu, Y.-M. Xu, J. Schisler
Abstract
CHIP (carboxyl terminus of heat shock 70-interacting protein) has long been recognized as an active member of the cellular protein quality control system given the ability of CHIP to function as both a co-chaperone and ubiquitin ligase. Mutations in CHIP are the driver of spinocerebellar autosomal recessive 16 (SCAR16), or cerebellar CHIPopathy, as we initially discovered this disease was caused by a loss of CHIP ubiquitin ligase function. The initial mutation describing SCAR16 was a missense mutation in the ubiquitin ligase domain of CHIP (p.T246M). Using multiple biophysical and cellular approaches, we demonstrate that T246M mutation results in structural disorganization and misfolding of the CHIP U-box domain, promoting oligomerization, and increased proteasome-dependent turnover. CHIP-T246M has no ligase activity, but maintains interactions with chaperones and alters the co-chaperone function of CHIP. To establish preclinical models of SCAR16, we engineered T246M at the endogenous locus in both mice and rats. Animals homozygous for T246M had both cognitive and motor cerebellar dysfunction distinct from those observed in the CHIP null animal model, as well as deficits in learning and memory, reflective of the cognitive deficits reported in SCAR16 patients. We conclude that the T246M mutation is not equivalent to the total loss of CHIP, supporting the concept that disease-causing CHIP mutations have different biophysical and functional repercussions on CHIP function that may directly correlate to the spectrum of clinical phenotypes observed in SCAR16 patients. Our findings both further expand our basic understanding of CHIP biology and provide meaningful mechanistic insight underlying the molecular drivers of SCAR16 disease pathology, which may be used to inform the development of novel therapeutics for this devastating disease.
- organism: mouse
- organism: rat
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Changes in protein function underlies the disease spectrum in patients with CHIP mutations
Sabrina C. Madrigal, Zipporah McNeil, … Jonathan Cummings Schisler·Journal of Biological ChemistryPeer-reviewed·Oct 16, 2019
- Domain-specific decoupling of co-chaperone and ligase functions in STUB1 underlies biochemical and clinical heterogeneity in SCA48
Selin Altınok, Ethan Paulаkonis, … Jonathan Cummings Schisler·bioRxiv·Nov 26, 2025
- Structures of Fab-stabilized CHIP reveal a conformational switch important in E3 ligase and chaperone functions
Aparna Unnikrishnan, Dong hee Chung, … Daniel R. Southworth·bioRxiv·May 15, 2025
- Interaction with the membrane-anchored protein CHIC2 constrains the ubiquitin ligase activity of CHIP
M. D. Callahan, M. Hodul, … J. E. Gestwicki·bioRxiv·Jul 17, 2023
- The CHCHD2-CHCHD10 protein complex is modulated by mitochondrial dysfunction and alters lipid homeostasis in the mouse brain.
Jule Gerlach, Paola Pireddu, … Roberta Filograna·Cell Death and DiseasePeer-reviewed·Oct 6, 2025
- Phosphorylation of a Cleaved Tau Proteoform at a Single Residue Inhibits Binding to the E3 Ubiquitin Ligase, CHIP
C. M. Nadel, K. Wucherer, … J. E. Gestwicki·bioRxiv·Aug 16, 2023